Anil Shahaji Khile

Title: Anil Shahaji Khile: Innovator in Pharmaceutical Processes

Introduction

Anil Shahaji Khile is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing key drug intermediates. With a total of 2 patents to his name, Khile's work is recognized for its commercial viability and industrial advantages.

Latest Patents

Khile's latest patents include innovative processes for preparing ticagrelor intermediate, specifically 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine. This invention provides improved methods for obtaining a substantially pure ticagrelor intermediate, which is essential for producing ticagrelor or its pharmaceutically acceptable salts in high yield and purity. Another significant patent involves quetiapine salts and their polymorphs. This invention relates to novel and stable salt forms of quetiapine, along with processes for their preparation and pharmaceutical compositions. The invention highlights various acid addition salts of quetiapine, which are crucial for effective treatment methods.

Career Highlights

Anil Khile is currently associated with Actavis Group Ptc Ehf, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficiency and effectiveness of drug formulations, contributing to advancements in medical treatments.

Collaborations

Khile collaborates with talented professionals in his field, including coworkers Jayesh Laljibhai Patel and Nitin Sharadchandra Pradhan. These collaborations foster a creative environment that drives innovation and enhances the quality of their pharmaceutical developments.

Conclusion

Anil Shahaji Khile's contributions to pharmaceutical processes exemplify the impact of innovation in medicine. His patents not only advance drug development but also improve treatment options for patients.